US Patent Issued to ZHEJIANG ECHON BIOMEDICAL, NANNING GENLOCI BIOMEDICAL on Sept. 15 for "Use of polypeptide in drug for preventing and treating pneumonia" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,734,211, issued on Sept. 15, was assigned to ZHEJIANG ECHON BIOMEDICAL Co. LTD. (Hangzhou, China) and NANNING GENLOCI BIOMEDICAL Co. LTD. (Nanning, China).

"Use of polypeptide in drug for preventing and treating pneumonia" was invented by Jianqun Ling (Hangzhou, China) and Qingping Lin (Hangzhou, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "A use of a polypeptide in a drug for preventing and treating pneumonia is provided. The polypeptide may effectively prevent and treat pneumonia, and may also be added with another therapeutic agent, excipient, carrier, or auxiliary ingredient to prepare a drug with the polypeptide and the therapeutic agent a...